INC Research Holdings Receives a Hold from Jefferies

By Austin Angelo

In a report issued on July 27, David Windley from Jefferies reiterated a Hold rating on INC Research Holdings (NASDAQ: INCR), with a price target of $62.50. The company’s shares closed on Friday at $55.45.

According to, Windley is a top 25 analyst with an average return of 25.1% and a 80.7% success rate. Windley covers the Services sector, focusing on stocks such as Quintiles Transnational, Quest Diagnostics Inc, and WellCare Health Plans.

INC Research Holdings has an analyst consensus of Moderate Buy, with a price target consensus of $64.75.

The company has a one year high of $61.10 and a one year low of $40.65. Currently, INC Research Holdings has an average volume of 951.3K.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

INC Research Holdings, Inc. engages in the clinical research on therapeutic alignment and expertise in Central Nervous System, Oncology, and other complex diseases. It operates through the Clinical Development Services and Phase I Services segments.